Symbols

SXTP

60 Degrees·NASDAQ

--(--)

SXTP Profile

60 Degrees Pharmaceuticals, Inc.

A growth-oriented specialty pharmaceutical company developing new treatments for infectious diseases

Industry

Pharmaceutical

Established Date

06/01/2022

Listing Date

07/12/2023

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.60degreespharma.com

Security Type

Common stock

Office address

1025 Connecticut Avenue NW Suite 1000 Washington, D.C. 20036

Business

Introduction

60 Degrees Pharmaceuticals, Inc., was incorporated in Delaware on June 1, 2022 after merging with a limited liability company of the same name. The Company is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of infectious diseases. Its product Arakoda (a malaria preventive drug) has been on the market since 2019, and its R&D pipeline also includes other vector, fungal and viral disease projects.